(Q36981274)

17 August 2017

1 reference

title

B-cells and humoral immunity in multiple sclerosis. Implications for therapy (English)

1 reference

17 August 2017

0 references

Sangjin Oh

1

1 reference

17 August 2017

Cornelia Cudrici

series ordinal

2

1 reference

17 August 2017

Takahiro Ito

series ordinal

3

1 reference

17 August 2017

Horea Rus

series ordinal

4

1 reference

17 August 2017

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

40

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

224-234

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-007-8009-6

17 August 2017

exact match

0 references

cites work

Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

Complement activation determines the therapeutic activity of rituximab in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-007-8009-6

C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection

21 January 2018

1 reference

12 December 2020

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

1 reference

12 December 2020

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

1 reference

12 December 2020

A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

B cells and antibodies in CNS demyelinating disease

1 reference

12 December 2020

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone

1 reference

12 December 2020

Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.

1 reference

12 December 2020

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody

1 reference

12 December 2020

Intrathecal activation of the complement system and disability in multiple sclerosis

1 reference

12 December 2020

CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone

1 reference

12 December 2020

Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases

1 reference

12 December 2020

Plasma exchange in acute multiple sclerosis. Design of a cooperative study

1 reference

12 December 2020

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

1 reference

12 December 2020

Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice

1 reference

12 December 2020

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

12 December 2020

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

12 December 2020

Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

1 reference

12 December 2020

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis

1 reference

12 December 2020

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

12 December 2020

Treatment with rituximab in benign and malignant hematologic disorders in children

1 reference

12 December 2020

Multiple sclerosis: brain immunoglobulin-G and albumin.

1 reference

12 December 2020

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

1 reference

12 December 2020

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

1 reference

12 December 2020

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

12 December 2020

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

12 December 2020

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

12 December 2020

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

1 reference

12 December 2020

Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy

1 reference

12 December 2020

Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis

1 reference

12 December 2020

The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions

1 reference

12 December 2020

AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS.

1 reference

12 December 2020

Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown

1 reference

12 December 2020

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

1 reference

12 December 2020

Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis

1 reference

12 December 2020

The significance of perivascular infiltrations in multiple sclerosis

1 reference

12 December 2020

Plasmapheresis in multiple sclerosis: preliminary findings

1 reference

12 December 2020

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

1 reference

12 December 2020

Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

1 reference

12 December 2020

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

12 December 2020

Plasmapheresis in multiple sclerosis: preliminary study

1 reference

12 December 2020

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

1 reference

12 December 2020

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

12 December 2020

The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis

1 reference

12 December 2020

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

1 reference

12 December 2020

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

12 December 2020

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

1 reference

12 December 2020

Induction of anti-myelin antibodies in EAE and their possible role in demyelination.

1 reference

12 December 2020

B cells regulate autoimmunity by provision of IL-10.

1 reference

12 December 2020

Pathogenetic role of autoantibodies in neurological diseases

1 reference

12 December 2020

B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis

1 reference

12 December 2020

B-cell differentiation in the CNS of patients with multiple sclerosis

1 reference

12 December 2020

Rituximab: expanding role in therapy for lymphomas and autoimmune diseases

1 reference

12 December 2020

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

1 reference

12 December 2020

10.1007/S12026-007-8009-6

Identifiers

DOI

1 reference

17 August 2017

1 reference